Published in Infect Immun on March 01, 1981
Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro. Infect Immun (1982) 2.29
Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis. Infect Immun (1987) 1.20
Amino acid sequence of a deltalike toxin from Staphylococcus epidermidis. Infect Immun (1990) 0.94
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry (1971) 66.90
Product of Staphylococcus aureus responsible for the scalded-skin syndrome. Infect Immun (1971) 4.19
Purification and properties of staphylococcal delta hemolysin. Infect Immun (1971) 3.19
Staphylococcal delta hemolysin: purification and characterization. Arch Biochem Biophys (1972) 1.55
Inhibition of Staphylococcus aureus delta hemolysin by phospholipids. Proc Soc Exp Biol Med (1972) 1.49
A new method for the preparation and some properties of staphylococcal delta-haemolysin. J Gen Microbiol (1971) 1.29
Effect of fatty acids on Staphylococcus aureus delta-toxin hemolytic activity. Infect Immun (1976) 1.01
Surface properties of membrane systems. Transport of staphylococcal delta-toxin from aqueous to membrane phase. Biochim Biophys Acta (1977) 0.99
Disruption of bacterial protoplasts and spheroplasts by staphylococcal delta hemolysin. Infect Immun (1971) 0.97
Assay of staphylococcal delta-haemolysin with fish erythrocytes. J Med Microbiol (1978) 0.90
Binding of radiolabeled Staphylococcus aureus delta-toxin to human erythrocytes. Infect Immun (1981) 0.87
Genetic structure of populations of Legionella pneumophila. J Bacteriol (1985) 7.30
Product of Staphylococcus aureus responsible for the scalded-skin syndrome. Infect Immun (1971) 4.19
Quantitative aspects of septicemia. Clin Microbiol Rev (1990) 2.79
Cord formation in BACTEC 7H12 medium for rapid, presumptive identification of Mycobacterium tuberculosis complex. J Clin Microbiol (1990) 2.55
Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem (2000) 2.47
Rapid identification of Candida species in blood cultures by a clinically useful PCR method. J Clin Microbiol (1997) 2.46
Detection of vancomycin-resistant enterococci in fecal samples by PCR. J Clin Microbiol (1997) 2.32
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem (2000) 2.30
Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes. J Clin Microbiol (1999) 1.56
Staphylococcus aureus: some host-parasite interactions. Ann N Y Acad Sci (1974) 1.53
Inhibition of Staphylococcus aureus delta hemolysin by phospholipids. Proc Soc Exp Biol Med (1972) 1.49
Plasmids as epidemiological markers in nosocomial Legionnaires' disease. J Infect Dis (1984) 1.47
Pseudo-outbreak of Legionella pneumophila serogroup 8 infection associated with a contaminated ice machine in a bronchoscopy suite. Infect Control Hosp Epidemiol (2009) 1.42
Hepatitis C: risk of a haircut. Ann Intern Med (1997) 1.39
Selective buffered charcoal-yeast extract medium for isolation of nocardiae from mixed cultures. J Clin Microbiol (1992) 1.37
Clumping of Staphylococcus aureus in the peritoneal cavity of mice. J Bacteriol (1966) 1.30
Increased cyclic adenosine 3',5'-monophosphate content in guinea pig ileum after exposure to Staphylococcus aureus delta-toxin. Infect Immun (1976) 1.28
Laboratory diagnosis of tuberculosis: past, present, and future. J Med Assoc Ga (1995) 1.23
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype. Am J Gastroenterol (2000) 1.21
Single-dose cefuroxime axetil in the treatment of uncomplicated gonorrhea: a controlled trial. Sex Transm Dis (1986) 1.21
Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 18Z. Infect Immun (1991) 1.16
Pulmonary infection of mice with Staphylococcus aureus. Infect Immun (1978) 1.14
Characterization of a bactericidal lipid developing within staphylococcal abscesses. Infect Immun (1981) 1.11
Primary Vibrio damsela septicemia. Clin Infect Dis (1996) 1.10
Factors involved in experimental staphylococcal peritonitis. Ann N Y Acad Sci (1965) 1.10
Rapid, direct antibiotic susceptibility testing of blood culture isolates using the Abbott Avantage system. Am J Clin Pathol (1986) 1.10
Epidermal toxin production by Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med (1982) 1.08
Partial characterization of a bactericidal system in staphylococcal abscesses. Infect Immun (1980) 1.08
Formation of intraperitoneal abscesses by Staphylococcus aureus. Infect Immun (1980) 1.07
Inhibition of water absorption in the intestine by Staphylococcus aureus delta-toxin. Infect Immun (1976) 1.05
Clinical and bacteriologic evaluation of BACTEC resin-containing blood culture medium. Am J Clin Pathol (1984) 1.04
Skin lesions produced by Staphylococcus aureus exfoliatin in hairless mice. Infect Immun (1972) 1.04
The phagocytosis and intracellular fate of staphylococci. Ann N Y Acad Sci (1965) 1.04
Enzymatic activities of Legionella pneumophila and Legionella-like organisms. J Clin Microbiol (1982) 1.02
Effect of fatty acids on Staphylococcus aureus delta-toxin hemolytic activity. Infect Immun (1976) 1.01
Reliability of latex agglutination tests for identification of Staphylococcus aureus resistant to oxacillin. J Clin Microbiol (1986) 1.01
Identification and characterization of Yersinia intermedia isolated from human feces. J Clin Microbiol (1987) 0.96
Staphylococcus aureus delta toxin as an enterotoxin. Ciba Found Symp (1985) 0.95
Electrophoretic and serological characterization of the lipopolysaccharides of Legionella pneumophila. Infect Immun (1986) 0.95
Neutralization of Staphylococcus aureus exfoliatin by antibody. Infect Immun (1972) 0.92
Characterization of endemic Providencia stuartii isolates from patients with urinary devices. Eur J Clin Microbiol (1984) 0.89
Growth cycle-induced changes in sensitivity of Staphylococcus aureus to bactericidal lipids from abscesses. J Med Microbiol (1993) 0.88
Binding of radiolabeled Staphylococcus aureus delta-toxin to human erythrocytes. Infect Immun (1981) 0.87
Modification of bactericidal fatty acids by an enzyme of Staphylococcus aureus. J Med Microbiol (1992) 0.87
Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes. J Clin Microbiol (2007) 0.87
Major outer membrane protein of Legionella pneumophila carries a species-specific epitope. J Clin Microbiol (1986) 0.86
Acanthamoeba castellani encephalitis following partially mismatched related donor peripheral stem cell transplantation. Transpl Infect Dis (2003) 0.85
Primary pulmonary infection caused by Mycobacterium terrae complex. Diagn Microbiol Infect Dis (1988) 0.85
Aureobacterium resistens sp. nov., exhibiting vancomycin resistance and teicoplanin susceptibility. FEMS Microbiol Lett (1998) 0.85
The production of bactericidal fatty acids from glycerides in staphylococcal abscesses. J Med Microbiol (1992) 0.84
Fluoroquinolone resistance in Streptococcus pneumoniae. Ann Intern Med (1999) 0.83
Staphylococcal population changes in experimentally infected mice: infection with suture-adsorbed and unadsorbed organisms grown in vitro and in vivo. J Infect Dis (1966) 0.82
Effect of Staphylococcus aureus delta toxin on Chinese hamster ovary cell morphology and Y-1 adrenal cell morphology and steroidogenesis. Infect Immun (1977) 0.82
The production of fatty acid modifying enzyme (FAME) and lipase by various staphylococcal species. J Med Microbiol (1992) 0.82
Host response to coagulase-negative staphylococci in abscesses induced within mice. J Med Microbiol (1993) 0.81
Subcutaneous multiplication of exfoliatin-producing staphylococci. Infect Immun (1976) 0.80
The production of a bactericidal monoglyceride in staphylococcal abscesses. J Med Microbiol (1992) 0.79
Increased tissue conductance and ion transport in guinea pig ileum after exposure to Staphylococcus aureus delta-toxin in vitro. Infect Immun (1978) 0.78
Supplementary rapid biochemical test panel for the API 20E bacterial identification system. J Clin Microbiol (1985) 0.78
The accumulation of bactericidal lipids in staphylococcal abscesses. J Med Microbiol (1992) 0.77
Necrotizing cerebritis in an allogeneic bone marrow transplant recipient due to Cladophialophora bantiana. J Clin Microbiol (1996) 0.77
Carotenoid pigment levels in Staphylococcus aureus and sensitivity to oleic acid. J Med Microbiol (1992) 0.77
Immunogenicity of Staphylococcus aureus delta-toxin. Infect Immun (1981) 0.76
Survival of Staphylococcus aureus in intraperitoneal abscesses. J Med Microbiol (1981) 0.76
Exfoliative dermatitis in an infant. Association with enterotoxin F-producing staphylococci. Am J Dis Child (1983) 0.75
Enhanced detection of Candida in blood cultures with the BACTEC 460 system by use of the aerobic-hypertonic (8B) medium. Epidemiol Infect (1990) 0.75
Use of selective buffered charcoal-yeast extract medium for isolation of nocardiae from mixed cultures. J Clin Microbiol (1993) 0.75
Levels of exfoliatin antitoxin in pooled human serum globulin. J Infect Dis (1979) 0.75
The magnitude of bacteremia in infants with group B streptococcal disease. Acta Paediatr Scand (1989) 0.75
Toxic shock syndrome and epidermal toxin. Ann Intern Med (1981) 0.75
Evaluation of disk approximation and agar dilution induction tests for demonstration of in vitro antagonism of cefotaxime by cefoxitin in Enterobacter species. Eur J Clin Microbiol (1987) 0.75
Effect of capsulation on the resistance of Staphylococcus aureus to the bactericidal lipids produced in abscesses. J Med Microbiol (1992) 0.75
Disc diffusion method to screen for high-level resistance to clindamycin and erythromycin in the Bacteroides fragilis group. Diagn Microbiol Infect Dis (1985) 0.75
Use of polymerase chain reaction for diagnosis of tuberculous meningitis. Pediatr Infect Dis J (1994) 0.75
An alternative strategy for infection control of anesthesia breathing circuits: a laboratory assessment of the Pall HME Filter. Anesth Analg (1991) 0.75
More on viral hepatitis. Am J Clin Pathol (2000) 0.75
Generalized exfoliation associated with Staphylococcus aureus infection. South Med J (1981) 0.75